CreatorsPublishersAdvertisers
View more in
Cancer

Atezolizumab plus Chemotherapy Displays Efficacy, Tolerability in NSCLC with Untreated Brain Metastases

onclive.com
 2021-09-10

Atezolizumab plus carboplatin and pemetrexed yielded a favorable safety and efficacy profile in patients with advanced non-squamous non-small cell lung cancer with untreated brain metastases. Atezolizumab (Tecentriq) plus carboplatin and pemetrexed yielded a favorable safety and efficacy profile in patients with advanced non-squamous non-small cell lung cancer (NSCLC) with...

www.onclive.com

Comments / 0

Comments / 0